Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

5.81
Delayed Data
As of Jul 31
 +0.06 / +1.04%
Today’s Change
2.98
Today|||52-Week Range
8.59
+22.83%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Squarer Ron
Chief Executive Officer
Buy3/01/201577,881$7.96$619.9K-29.15%
Lefkoff Kyle A
Director
Sale3/03/201570,000$8.00$560.0K-27.83%
Squarer Ron
Chief Executive Officer
Sale3/02/201540,000$8.25$330.0K-29.15%
Robbins Andrew R
Senior Vice President-Commercial Operations
Buy3/01/201532,069$7.96$255.3K-29.15%
Baum Charles M
Director
Sale5/08/201525,000$7.38$184.5K-22.33%
Moore John R /array Biopharma/
Vice President & General Counsel
Buy3/01/201522,906$7.96$182.3K-29.15%
Robbins Andrew R
Senior Vice President-Commercial Operations
Sale3/02/201521,576$8.25$178.0K-29.15%
Sandor Victor
Buy3/01/201517,440$7.96$138.8K-29.15%
Baum Charles M
Director
Buy5/08/201525,000$3.86$96.5K-22.33%
Snitman David L
Buy3/01/201511,453$7.96$91.2K-29.15%
Page of 3